Grace Frank, senior copy editor —

Grace served as editor-in-chief for BioNews from June 2016 to June 2019 before returning to editing. A longtime newspaper editor and reporter, she was a Pulitzer Prize nominee for an investigative series into eye surgeries wrongly conducted outside a clinical trial. She holds a master’s degree in international relations from the University of Chicago and a bachelor's degree in political science from Rutgers University. Grace lives in France with her extended people-and-pets family.

Articles by Grace Frank

FAQs About Evrysdi (Risdiplam)

Evrysdi (risdiplam) is an oral liquid treatment approved in the U.S. for infants through adults with spinal muscular atrophy (SMA) — patients age 2 months and older with any disease type. Roche and Genentech developed Evrysdi in collaboration with PTC Therapeutics and the SMA…

FDA Issues No Fines for Data Problems in Zolgensma’s Application

The U.S. Food and Drug Administration has decided not to fine or otherwise sanction Novartis for manipulated data included in the application that led to Zolgensma‘s approval to treat spinal muscular atrophy (SMA) in children up to age 2. The FDA was not informed until roughly a month after it announced…